Alpine Global Management, LLC - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 119 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.

Quarter-by-quarter ownership
Alpine Global Management, LLC ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$584,000
-62.5%
197,888
-60.4%
0.15%
-23.3%
Q1 2022$1,556,000
+84.1%
500,000
+100.0%
0.19%
+55.6%
Q4 2021$845,000
+482.8%
250,000
+886.6%
0.12%
+327.6%
Q4 2020$145,000
-25.3%
25,339
+69.7%
0.03%
-37.0%
Q1 2018$194,000
-37.6%
14,933
-55.8%
0.05%
-35.2%
Q4 2017$311,00033,7970.07%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,641,804$7,454,0006.54%
COMMODORE CAPITAL LP 2,983,513$13,545,0005.40%
Foresite Capital Management IV, LLC 1,787,094$8,113,0000.97%
Avoro Capital Advisors LLC 10,300,000$46,762,0000.81%
Boxer Capital, LLC 4,000,000$18,160,0000.62%
Sio Capital Management, LLC 562,339$2,553,0000.52%
ACUTA CAPITAL PARTNERS, LLC 315,341$1,432,0000.52%
CM Management, LLC 150,000$681,0000.51%
APIS CAPITAL ADVISORS, LLC 120,000$545,0000.50%
Versant Venture Management, LLC 543,753$2,469,0000.48%
View complete list of CYMABAY THERAPEUTICS INC shareholders